Introduction:
Dr. Mayur Narkhede is an assistant professor at the University of Alabama, Birmingham. He completed his residency in Internal Medicine at the Cleveland Clinic Foundation from 2013 to 2016 and a Hematology and Medical Oncology fellowship from Georgetown University in Washington, D.C. He was the chief fellow from 2018 to 2019. He is board-certified in Internal Medicine, Hematology, and Medical Oncology. Dr. Narkhede specialized in the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, and Chronic Lymphocytic Leukemia.
Clinical Interests:
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, and Chronic Lymphocytic Leukemia.
Research: Dr. Narkhede is an active clinical and translational researcher focusing on lymphoid malignancies and Chronic Lymphocytic Leukemia. He is a principal investigator for multiple phase 1 and phase 2 clinical trials conducted at UAB. In addition, his research interest also involves studying imaging and biochemical biomarkers of treatment response and toxicities in non-Hodgkin lymphomas.